Qingdao Vland Biotech INC. (SHA:603739)
China
· Delayed Price · Currency is CNY 13.81
-0.01 (-0.07%)
Jun 4, 2025, 2:45 PM CST
SHA:603739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 59.49 | 62.64 | 80.71 | 69.84 | 132.57 | 108.98 | Upgrade
|
| Depreciation & Amortization | 110.41 | 110.41 | 73.79 | 65.71 | 51.7 | 42.87 | Upgrade
|
| Other Amortization | 1.78 | 1.78 | 0.49 | 0.95 | 0.2 | 0.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.6 | 0.6 | -0 | 0.35 | -0.05 | -0.14 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.55 | 0.55 | 3 | - | 1.98 | 4.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -7.08 | -7.08 | -15.64 | -3.48 | -7.63 | 0.45 | Upgrade
|
| Provision & Write-off of Bad Debts | 3.92 | 3.92 | 12.98 | 11.87 | 7.82 | 5.96 | Upgrade
|
| Other Operating Activities | 80.84 | 56.57 | 41.5 | 29.97 | 19.65 | 15.1 | Upgrade
|
| Change in Accounts Receivable | -40.88 | -40.88 | -36.65 | -110.01 | -91.03 | -32.33 | Upgrade
|
| Change in Inventory | 13.84 | 13.84 | -35.62 | -19.16 | -33.19 | -21.58 | Upgrade
|
| Change in Accounts Payable | -6.46 | -6.46 | 33.15 | 51.03 | 10.24 | 47.55 | Upgrade
|
| Operating Cash Flow | 216.53 | 195.41 | 153.59 | 95.31 | 89.51 | 173 | Upgrade
|
| Operating Cash Flow Growth | 70.95% | 27.22% | 61.16% | 6.47% | -48.26% | 164.82% | Upgrade
|
| Capital Expenditures | -128.65 | -104.72 | -215.64 | -342.02 | -493.58 | -211.83 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.71 | 2.08 | 0.93 | 0.11 | 0.11 | 0.31 | Upgrade
|
| Cash Acquisitions | -18.36 | -18.36 | -16.84 | -0.91 | -45.96 | - | Upgrade
|
| Divestitures | 0.41 | 0.41 | -0.2 | - | - | - | Upgrade
|
| Investment in Securities | 82.31 | 65.43 | -75.81 | -103.12 | -75.43 | 82.05 | Upgrade
|
| Other Investing Activities | 2.27 | 12.71 | 10.91 | 17.77 | 8.13 | 33.74 | Upgrade
|
| Investing Cash Flow | -60.31 | -42.46 | -296.66 | -428.17 | -606.73 | -95.73 | Upgrade
|
| Long-Term Debt Issued | - | 842.68 | 661.27 | 489.55 | 360 | 216.18 | Upgrade
|
| Total Debt Issued | 852.19 | 842.68 | 661.27 | 489.55 | 360 | 216.18 | Upgrade
|
| Long-Term Debt Repaid | - | -915.25 | -461.16 | -203.7 | -192.44 | -179.9 | Upgrade
|
| Total Debt Repaid | -897.1 | -915.25 | -461.16 | -203.7 | -192.44 | -179.9 | Upgrade
|
| Net Debt Issued (Repaid) | -44.91 | -72.57 | 200.11 | 285.85 | 167.56 | 36.28 | Upgrade
|
| Issuance of Common Stock | - | - | 7.76 | 4.74 | 498.82 | - | Upgrade
|
| Common Dividends Paid | -54.82 | -55.23 | -39.77 | -52.77 | -37.79 | -32.55 | Upgrade
|
| Other Financing Activities | -14.39 | -13.67 | -11.74 | -10.1 | -48.03 | -3.87 | Upgrade
|
| Financing Cash Flow | -114.12 | -141.47 | 156.36 | 227.72 | 580.56 | -0.14 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.13 | 0.13 | 0.73 | 1.07 | -1.47 | -1.23 | Upgrade
|
| Net Cash Flow | 42.23 | 11.61 | 14.03 | -104.07 | 61.87 | 75.9 | Upgrade
|
| Free Cash Flow | 87.88 | 90.69 | -62.05 | -246.72 | -404.06 | -38.83 | Upgrade
|
| Free Cash Flow Margin | 6.54% | 6.87% | -5.18% | -21.21% | -35.11% | -4.04% | Upgrade
|
| Free Cash Flow Per Share | 0.36 | 0.36 | -0.25 | -0.95 | -1.65 | -0.17 | Upgrade
|
| Cash Income Tax Paid | 87.46 | 83.84 | 80.82 | 44.62 | 58.15 | 47.79 | Upgrade
|
| Levered Free Cash Flow | -18.4 | 10.14 | 20.05 | -241.42 | -418.19 | -87.8 | Upgrade
|
| Unlevered Free Cash Flow | -4.35 | 23.82 | 29.56 | -236.94 | -416.86 | -86.69 | Upgrade
|
| Change in Net Working Capital | 49.84 | 45.35 | -106.66 | 18.48 | 64.27 | -12.19 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.